Full-Time
Posted on 5/16/2026
Global life sciences R&D services
$100k - $138k/yr
San Francisco, CA, USA
In Person
Labcorp provides end-to-end R&D services for life sciences and agricultural clients, including crop protection, with testing and regulatory support. It runs physicochemical analyses, safety assessments, and inhalation toxicology studies using specialized labs to evaluate inhaled substances. It differentiates itself with a global footprint and an integrated set of services across the product lifecycle, including regulatory submissions. Its goal is to help clients bring safe, effective products to market efficiently by applying rigorous science and scalable testing.
Company Size
10,001+
Company Stage
IPO
Headquarters
Burlington, Vermont
Founded
1976
Help us improve and share your feedback! Did you find this helpful?
People at LabCorp who can refer or advise you
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
401(k) Retirement Plan
Unlimited Paid Time Off
Tuition Reimbursement
Employee Stock Purchase Plan
Labcorp expands Epic collaboration to integrate full diagnostic test menu through Aura platform. Labcorp has announced an expanded collaboration with Epic Systems aimed at improving how hospitals and health systems access laboratory testing services through electronic health record (EHR) workflows. Under the expanded agreement, Labcorp's full diagnostic test menu will become available through Epic's Aura platform, enabling clinicians to order tests and receive results directly within existing Epic workflows. The move is expected to simplify laboratory integrations, reduce operational complexity for health systems and improve access to advanced diagnostics nationwide. What the expanded collaboration includes? The integration builds on the existing availability of Invitae genetic tests through Epic Aura. With the expansion, hospitals and health systems using Epic will gain access to: * Labcorp's full diagnostic testing menu * Newly introduced laboratory tests * Advanced and specialty diagnostics * Integrated ordering and reporting workflows According to the companies, the collaboration is designed to streamline the process of connecting healthcare systems with external laboratory providers. Reducing IT complexity for health systems. Healthcare organizations often face significant technical and operational challenges when integrating laboratory systems with EHR platforms. These projects can involve: * Lengthy onboarding timelines * High implementation costs * Complex interface management * Ongoing maintenance requirements By leveraging Epic's Aura platform, the companies say the integration will reduce much of that burden through standardized connectivity and centralized content management. The goal is to shorten implementation timelines while minimizing maintenance and administrative overhead for hospitals and health systems. Seamless lab ordering within clinical workflows. One of the key advantages of the expanded integration is improved workflow efficiency for clinicians and care teams. Through Aura, clinicians will be able to: * Order Labcorp tests directly within Epic * Receive discrete laboratory results inside patient records * Reduce manual data entry * Minimize workflow disruptions and workarounds The integration is intended to help clinicians order appropriate tests more efficiently while improving access to diagnostic information within routine patient care workflows. Improving Access to advanced diagnostics. The collaboration also expands access to Labcorp's evolving portfolio of advanced diagnostics and specialty testing services. According to Labcorp, health systems using Epic will be able to access new tests as they are introduced without requiring separate integration projects. This could be particularly valuable in areas such as: * Genetic testing * Precision medicine * Oncology diagnostics * Specialized biomarker testing * Rare disease screening Leadership perspectives. Bryan Vaughn, executive vice president and president of Diagnostics at Labcorp, said the expanded collaboration reflects the company's broader strategy of supporting the changing needs of hospitals and health systems. According to Vaughn, simplifying laboratory integration while embedding Labcorp's test menu directly into Epic workflows creates a stronger foundation for future diagnostic innovation. Meanwhile, Sumit Rana, president of Epic Systems, stated that the expanded use of Aura will help clinicians order the correct tests more efficiently and enable patients to receive faster diagnostic answers. Why this matters? Laboratory diagnostics play a critical role in modern healthcare decision-making, but fragmented systems and disconnected workflows often create inefficiencies for providers. The expanded Labcorp-Epic integration addresses several major industry challenges, including: * Interoperability between laboratories and EHR systems * Administrative burden on healthcare providers * Delays in diagnostic workflows * Access to advanced testing capabilities As healthcare systems increasingly prioritize integrated digital workflows and precision medicine, partnerships between laboratory providers and EHR companies are becoming strategically important. Growing importance of ehr-integrated diagnostics. The collaboration also highlights a broader trend toward tighter integration between diagnostics companies and healthcare technology platforms. By embedding laboratory services directly within clinical workflows, healthcare organizations aim to: * Improve care coordination * Reduce operational inefficiencies * Accelerate diagnostic decision-making * Enhance patient outcomes For Labcorp, the partnership further strengthens its position in the rapidly evolving digital diagnostics ecosystem, while expanding the reach of its testing portfolio across hospitals and health systems using Epic nationwide.
Fox Chase Cancer Center, Labcorp collaborate on clinical trial for Plasma Detect Genome MRD in NSCLC. NEW YORK - Temple Health's Fox Chase Cancer Center and Laboratory Corporation of America announced Tuesday a clinical trial collaboration to evaluate the use of Labcorp's whole-genome sequencing Plasma Detect Genome MRD to assess the risk of recurrence in patients with early stage non-small cell lung cancer (NSCLC). Get the full story with 360dx Premium. Only $95 for the first 90 days. Full site access Interest-based email alerts Premium Access - Trial Offer $95.00 for 3 month
Labcorp launches rapid fentanyl test with 48-hour detection window. * April 15, 2026 While fentanyl overdose deaths have been falling in recent years, use of the drug remains a major public health crisis in the U.S., and now Labcorp is launching a new test designed to detect the drug's use for up to 48 hours after exposure. Fields (*) Mark are Required
Labcorp has launched an AI-powered real-world data platform to accelerate Alzheimer's disease research, developed in collaboration with Amazon Web Services and Datavant. The platform aims to generate insights in minutes that previously required months of data analysis. The system combines Labcorp's diagnostic and genomic datasets with medical claims data, using AWS AI services including Amazon Bedrock and Amazon SageMaker. It enables researchers to identify patient cohorts, track disease progression and measure treatment effectiveness across diverse populations using deidentified healthcare data. With over 7.2 million Americans living with Alzheimer's and annual care costs exceeding $380 billion in the US, the platform addresses traditional challenges of fragmented data and lengthy preparation times. Initial validation will complete in spring 2026, with plans to expand into inflammatory diseases, cardiometabolic conditions, women's health and oncology.
Labcorp, CHOP to develop, commercialize specialty pediatric diagnostics. NEW YORK - Laboratory Corporation of America and Children's Hospital of Philadelphia (CHOP) on Monday announced a strategic collaboration to accelerate the development of and access to specialized pediatric diagnostics. Get the full story with 360dx Premium. Only $95 for the first 90 days. Full site access Interest-based email alerts Premium Access - Trial Offer $95.00 for 3 month